HSTM — HealthStream Cashflow Statement
0.000.00%
Last trade - 00:00
- $778.49m
- $694.82m
- $279.06m
- 99
- 29
- 92
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 15.8 | 14.1 | 5.84 | 12.1 | 15.2 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 11.1 | 7.04 | 14.6 | 11.7 | 15.7 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 8.8 | -19.7 | -16.4 | -11.2 | -6.33 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 65.7 | 35.9 | 42.4 | 51.2 | 64 |
Capital Expenditures | -36.5 | -18.8 | -25.3 | -25.1 | -28 |
Purchase of Fixed Assets | |||||
Software Development Costs | |||||
Other Investing Cash Flow Items | -31 | -91.6 | -0.377 | -3.29 | -28.6 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -67.5 | -110 | -25.7 | -28.4 | -56.6 |
Financing Cash Flow Items | -1.07 | -0.435 | -1.18 | -0.565 | -1.05 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | -0.916 | -20.5 | -6.21 | -23.7 | -13 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.78 | -95 | 10.3 | -0.882 | -5.69 |